Drug Utilization Management and Clinical Edits Tools (Revised)
Summary
This is a guidance policy update (revised November 26, 2025) that clarifies Humana's Drug Utilization Management and Clinical Edits Tools across Medicare and multiple state Medicaid programs. The policy outlines how Humana applies prospective clinical edits (prior authorization, quantity limits, step therapy, duplication edits, drug/drug interactions, accumulation edits, and age/gender/disease/pregnancy edits) to ensure safe and cost-effective medication therapy. The policy specifies grandfathering exceptions for four drug classes (antidepressants, antipsychotics, anticonvulsants for epilepsy, antineoplastics, antiretrovirals, and immunosuppressants) and clarifies that drug samples do not count as treatment experience for prior authorization or step therapy requirements.
Get alerts when payers change rules like this one
We check Humana and other payers every day and email you when a change matches your specialty and state.